Uvax Bio Appoints Kevin O'Neill as Interim Chief Executive Officer
Uvax Bio, LLC, ("Uvax” or "the Company”) a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and deliver novel 1c-SApNP ® protein-based vaccines, today announced the appointment of Chief Business Officer Kevin O'Neill to Interim Chief Executive Officer (CEO).
One month into his new position, Stéphane de La Faverie, president and chief executive officer of the Estée Lauder Cos., is ...
Asian News International on MSN20h
Chris Dehring begins tenure as Chief Executive Officer of Cricket West IndiesCricket West Indies (CWI) officially welcomed Chris Dehring as he began his tenure as Chief Executive Officer (CEO) on Monday ...
Sony Group said Chief Operating Officer Hiroki Totoki would become chief executive on April 1.
A new strategic plan for the Houston-based offshore oil producer, which lost two leaders in six months, is a top priority for ...
Ghana-focused player confirmed appointment of Richard Miller on Tuesday as interim chief executive and chief financial ...
Ajit Mohan will be responsible for growing Snap's advertising business across all regions and leading the social media company's revenue product and business operations organisations ...
CONCORD, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Highly regarded executive, Germán Piderit, has joined Wyse Meter Solutions Inc. (“Wyse”) as Chief Operating Officer, effective January 27, 2025.
The council is set to select from in-house for its interim chief executive, the most senior officer role in the local ...
Match Group Inc. named Zillow Group Inc. co-founder Spencer Rascoff as its new chief executive officer, replacing Bernard Kim ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback